Holen Sie sich die Stockscreener-App
2.25
11.94%
0.24
Schlusskurs vom Vortag:
$2.01
Offen:
$2.01
24-Stunden-Volumen:
560.40K
Relative Volume:
0.11
Marktkapitalisierung:
$7.37M
Einnahmen:
$1.31M
Nettoeinkommen (Verlust:
$-7.47M
KGV:
-0.312
EPS:
-7.2117
Netto-Cashflow:
$-5.11M
1W Leistung:
+28.57%
1M Leistung:
-18.18%
6M Leistung:
+592.31%
1J Leistung:
+807.99%
1-Tages-Spanne:
$1.94
$2.25
1-Wochen-Bereich:
$1.55
$2.25
52-Wochen-Spanne:
$0.197
$8.90
Scisparc Ltd Stock (SPRC) Company Profile
Vergleichen Sie SPRC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SPRC
Scisparc Ltd
|
2.25 | 6.59M | 1.31M | -7.47M | -5.11M | -7.2117 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.88 | 112.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
699.24 | 73.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
417.70 | 56.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
892.07 | 55.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.92 | 41.92B | 447.02M | -1.18B | -906.14M | -6.1812 |
Scisparc Ltd Aktie (SPRC) Neueste Nachrichten
SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
SciSparc Stock Soars Pre-Market After Snapping Up Patents For Next-Gen Endoscopy Tech - MSN
SciSparc Shares Experience Pre-Bell Dip Following Quiet Session - timothysykes.com
Will SciSparc Ltd. stock outperform growth indexesJuly 2025 Final Week & Growth-Oriented Investment Plans - Newser
NeuroThera to acquire 55% stake in quantum computing bio data company - MSN
SciSparc Shares Slide After Revealing Plans to Acquire MUSE Endoscopic System IP - MSN
SciSparc’s NeuroThera Labs Eyes Quantum Leap with New Acquisition - TipRanks
SciSparc Ltd. Announces NeuroThera Labs' Planned Acquisition of Quantum Computing Bio Data Company - Quiver Quantitative
SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company - The Manila Times
SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to - GlobeNewswire
SciSparc plans to enter GERD device market with IP portfolio acquisition - MSN
symbol__ Stock Quote Price and Forecast - CNN
SciSparc (SPRC) Stock Analysis Report | Financials & Insights - Benzinga
SciSparc stock tumbles after announcing MUSE system acquisition plans By Investing.com - Investing.com UK
SciSparc Ltd. (SPRC) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
SciSparc stock tumbles after announcing MUSE system acquisition plans - Investing.com
SciSparc to acquire MUSE endoscopic system patents from Xylo By Investing.com - Investing.com Nigeria
SciSparc to acquire MUSE endoscopic system patents from Xylo - Investing.com
SciSparc Plans on Entering the Multi-Billion-Dollar GERD Device Market with Acquisition of an Approved IP Portfolio - The Manila Times
Scisparc plans on entering the multi-billion-dollar GERD device market with acquisition of an approved IP portfolio - marketscreener.com
SciSparc Ltd. Signs Agreement to Acquire Patents and Intellectual Property for Innovative MUSE™ Endoscopic System from Xylo Technologies Ltd. - Quiver Quantitative
Scisparc Plans On Entering The Multi-Billion-Dollar Gerd Device Market With Acquisition Of An Approved IP Portfolio - TradingView
SciSparc (Nasdaq: SPRC) signs MUSE GERD IP term sheet, plans 19.99% share issue - Stock Titan
SciSparc acquires Xylo Technologies' innovative endoscopic portfolio - Indian Pharma Post
SciSparc Ltd. (SPRC) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
SciSparc Ltd. Announces $2.2 Million Securities Offering - The Globe and Mail
Form 424B5 SciSparc Ltd. - StreetInsider
Is SciSparc Ltd a good long term investmentStock Buyback Announcements & Free Tap Rapid Wealth - earlytimes.in
What analysts say about SciSparc Ltd stockMid Cap Growth Trends & Minimal Investment Trading Tips - earlytimes.in
SciSparc Shares Surge After Company Moves to Acquire GERD Treatment Technology - MSN
SciSparc’s Stock Slip: Investment Opportunity? - timothysykes.com
SciSparc Ltd. to Acquire Xylo’s Patents for Endoscopic Systems - TipRanks
[6-K] SciSparc Ltd. Current Report (Foreign Issuer) | SPRC SEC FilingForm 6-K - Stock Titan
SciSparc’s Patent Surge: Buy or Hold? - StocksToTrade
SciSparc Ltd. (SPRC) Stock: Jumps as Company Expands into High-Growth GERD Device Market - parameter.io
Why SciSparc Stock Is Gaining Today - Benzinga
SciSparc to acquire endoscopic system patents from Xylo Technologies By Investing.com - Investing.com Nigeria
SciSparc Stocks Surge: A Strategic Leap Forward? - timothysykes.com
SciSparc stock soars after acquiring GERD treatment technology By Investing.com - Investing.com Nigeria
SciSparc stock soars after acquiring GERD treatment technology - Investing.com India
SciSparc to acquire treasury of patents for medical endoscopy systems - TipRanks
Scisparc to acquire treasury of patents for innovative medical endoscopy systems - marketscreener.com
Finanzdaten der Scisparc Ltd-Aktie (SPRC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):